ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,728,494 | -34.2% | 146,457 | -8.2% | 0.00% | 0.0% |
| Q2 2023 | $4,146,694 | -9.8% | 159,611 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $4,597,900 | -2.9% | 160,094 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $4,733,839 | +18.9% | 159,927 | -4.4% | 0.00% | 0.0% |
| Q3 2022 | $3,982,000 | +3.5% | 167,305 | -3.0% | 0.00% | 0.0% |
| Q2 2022 | $3,847,000 | -16.9% | 172,419 | -6.5% | 0.00% | 0.0% |
| Q1 2022 | $4,631,000 | -38.1% | 184,381 | -11.6% | 0.00% | 0.0% |
| Q4 2021 | $7,476,000 | -19.4% | 208,628 | -4.3% | 0.00% | -50.0% |
| Q3 2021 | $9,277,000 | -2.2% | 217,962 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $9,489,000 | +20.5% | 219,202 | +13.5% | 0.00% | +100.0% |
| Q1 2021 | $7,876,000 | -24.3% | 193,084 | -16.0% | 0.00% | -50.0% |
| Q4 2020 | $10,399,000 | +22.8% | 229,759 | -4.0% | 0.00% | 0.0% |
| Q3 2020 | $8,468,000 | -9.1% | 239,279 | -3.1% | 0.00% | 0.0% |
| Q2 2020 | $9,314,000 | +68.4% | 246,837 | +29.0% | 0.00% | 0.0% |
| Q1 2020 | $5,530,000 | -44.5% | 191,297 | -0.4% | 0.00% | 0.0% |
| Q4 2019 | $9,957,000 | -7.4% | 192,054 | -2.0% | 0.00% | -33.3% |
| Q3 2019 | $10,758,000 | +34.6% | 196,009 | -0.4% | 0.00% | +50.0% |
| Q2 2019 | $7,995,000 | +36.8% | 196,841 | +1.8% | 0.00% | +100.0% |
| Q1 2019 | $5,845,000 | -10.2% | 193,299 | -0.2% | 0.00% | -50.0% |
| Q4 2018 | $6,508,000 | -22.0% | 193,606 | -2.1% | 0.00% | 0.0% |
| Q3 2018 | $8,343,000 | +32.1% | 197,806 | +0.2% | 0.00% | 0.0% |
| Q2 2018 | $6,316,000 | -36.3% | 197,347 | -1.0% | 0.00% | -33.3% |
| Q1 2018 | $9,915,000 | -7.8% | 199,422 | +0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,750,000 | -6.9% | 199,413 | +0.2% | 0.00% | 0.0% |
| Q3 2017 | $11,541,000 | +15.1% | 198,987 | -2.1% | 0.00% | 0.0% |
| Q2 2017 | $10,029,000 | +18.4% | 203,260 | +4.2% | 0.00% | +50.0% |
| Q1 2017 | $8,474,000 | -7.9% | 195,071 | +3.8% | 0.00% | -33.3% |
| Q4 2016 | $9,201,000 | +4.2% | 187,943 | +1.9% | 0.00% | 0.0% |
| Q3 2016 | $8,828,000 | -10.7% | 184,499 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $9,891,000 | +17.0% | 184,355 | -2.5% | 0.00% | 0.0% |
| Q1 2016 | $8,453,000 | +18.3% | 189,026 | +0.9% | 0.00% | +50.0% |
| Q4 2015 | $7,145,000 | +24.7% | 187,258 | +4.0% | 0.00% | 0.0% |
| Q3 2015 | $5,729,000 | -3.6% | 180,018 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $5,942,000 | -19.9% | 179,919 | -0.2% | 0.00% | 0.0% |
| Q1 2015 | $7,420,000 | +1.5% | 180,220 | +0.5% | 0.00% | 0.0% |
| Q4 2014 | $7,309,000 | +8.3% | 179,411 | -2.5% | 0.00% | 0.0% |
| Q3 2014 | $6,748,000 | -10.0% | 184,066 | +13.8% | 0.00% | 0.0% |
| Q2 2014 | $7,495,000 | +4.1% | 161,765 | -7.7% | 0.00% | 0.0% |
| Q1 2014 | $7,202,000 | +3.2% | 175,225 | -4.2% | 0.00% | 0.0% |
| Q4 2013 | $6,978,000 | +62.9% | 182,849 | +2.0% | 0.00% | 0.0% |
| Q3 2013 | $4,284,000 | +37.0% | 179,305 | -2.6% | 0.00% | +100.0% |
| Q2 2013 | $3,128,000 | – | 184,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |